| |
| |
|
| Insider
Information: |
Commodore Capital Lp |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
7,109,170 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$3,788,417 |
|
|
| Total
Shares |
7,109,170 |
|
|
| Total
Value |
$3,788,417 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Satsuma Pharmaceuticals, Inc. |
STSA |
10% Owner |
2021-10-15 |
0 |
2022-11-14 |
461,286 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
|
0 |
2023-02-23 |
1,448,640 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
10% Owner |
2023-06-20 |
0 |
2024-01-10 |
4,400,000 |
Premium* |
|
|
Vistagen Therapeutics Inc |
VTGN |
10% Owner |
2023-08-07 |
0 |
2023-08-07 |
799,244 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VERA |
Vera Therapeutics, Inc. |
10% Owner |
– – • |
2024-01-10 |
4 |
S |
$18.00 |
$18,900,000 |
I/I |
(1,050,000) |
4,400,000 |
0 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
10% Owner |
– – • |
2023-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
799,244 |
|
% |
|
| VTGN |
Vistagen Therapeutics Inc |
10% Owner |
– – • |
2023-08-07 |
4 |
B |
$23.15 |
$17,961,079 |
I/I |
775,756 |
1,575,000 |
1.5 |
% |
|
| VERA |
Vera Therapeutics, Inc. |
10% Owner |
– – • |
2023-06-20 |
4 |
B |
$15.17 |
$6,799,004 |
I/I |
448,217 |
5,450,000 |
1.5 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
10% Owner |
– – • |
2023-06-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,001,783 |
|
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-02-23 |
4 |
B |
$22.07 |
$13,723 |
I/I |
622 |
718,749 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
729,891 |
1,448,640 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-02-22 |
4 |
B |
$5.11 |
$120,488 |
I/I |
23,565 |
2,872,513 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-02-21 |
4 |
B |
$5.25 |
$43,010 |
I/I |
8,194 |
2,848,948 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-02-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,840,754 |
|
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-14 |
4 |
S |
$0.71 |
$2,294,500 |
I/I |
(3,250,000) |
461,286 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-24 |
4 |
B |
$5.42 |
$15,837 |
I/I |
2,922 |
3,711,286 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-11 |
4 |
B |
$6.05 |
$48,043 |
I/I |
7,941 |
3,695,160 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-10 |
4 |
B |
$5.85 |
$56,289 |
I/I |
9,622 |
3,687,219 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-08 |
4 |
B |
$5.99 |
$3,354 |
I/I |
560 |
3,677,597 |
1.42 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-05 |
4 |
B |
$5.95 |
$46,410 |
I/I |
7,800 |
3,677,037 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-04 |
4 |
B |
$5.88 |
$8,232 |
I/I |
1,400 |
3,669,237 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-11-02 |
4 |
B |
$5.64 |
$50,083 |
I/I |
8,880 |
3,667,837 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-29 |
4 |
B |
$5.71 |
$254,957 |
I/I |
44,651 |
3,658,957 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-28 |
4 |
B |
$5.55 |
$83,705 |
I/I |
15,082 |
3,614,306 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-27 |
4 |
B |
$5.45 |
$215,716 |
I/I |
39,581 |
3,599,224 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-22 |
4 |
B |
$5.51 |
$152,236 |
I/I |
27,629 |
3,559,643 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-21 |
4 |
B |
$5.40 |
$177,206 |
I/I |
32,816 |
3,532,014 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-20 |
4 |
B |
$5.44 |
$221,207 |
I/I |
40,663 |
3,499,198 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-19 |
4 |
B |
$5.07 |
$444,031 |
I/I |
87,580 |
3,458,535 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
